Innovative and Customizable Services for EOSC Exchange

Published by European Commission (EC)

European Open Science Cloud

The aim is to provide researchers with a set of highly innovative new services via the EOSC Exchange. These would exploit, in a structural way, the cloud-based EOSC Core technologies and horizontal European compute and data management capacities that are part of the Minimum Viable EOSC platform in production.

To be customizable and scalable, all developments should be tested against 2-3 real life use cases from a variety of scientific domains. The proposals should cooperate with the EOSC Testbed facility (to be funded under HORIZON-INFRA-2023-EOSC-01-04) as well as other relevant and related projects and e-Infrastructures and large user communities. Joint use cases and testing across individual project boundaries are encouraged.

View this resource Bookmark this resource

GenOmics 2024

Published by FONDATION MALADIES RARES

Genomics

The Fondation Maladies Rares is pleased to announce the launch of its “GenOmics” 2024 call for projects.

The aim of this AAP is to support hypothesis-driven research projects aimed at exploring the genetic and molecular basis of rare diseases using NGS approaches (WES, WGS, RNA-seq, small RNA-seq, ChIP-seq, Methyl-seq, etc.).

Support from the Fondation Maladies Rares will give project leaders access to innovative high-throughput sequencing technologies for the analysis of exomes, genomes, transcriptomes or epigenomes.

View this resource Bookmark this resource

Open Call 2024

Published by COST

COST

Participants are invited to submit COST Action proposals contributing to the scientific, technological, economic, cultural or societal knowledge advancement and development of Europe. Multi- and interdisciplinary proposals are encouraged.

The Open Call Action proposal submission, evaluation, selection and approval (SESA) procedure is fully science and technology-driven and will ensure a simple, transparent and competitive proposal evaluation and selection process, reflecting the bottom-up, open and inclusive principles of COST.

Participants planning to submit a proposal for a COST Action will need to refer to the SESA guidelines and to the Open Call Announcement available on the Documents and Guidelines page.

View this resource Bookmark this resource

Development of Practical Guidance and Recommendations for Using Real World Data/Real World Evidence in Healthcare Decision-Making

Published by IHI

IHI

The Innovative Health Initiative Joint Undertaking (IHI JU) is a partnership between the European Union
and industry associations representing the sectors involved in healthcare, namely COCIR (medical
imaging, radiotherapy, health ICT and electromedical industries); EFPIA, including Vaccines Europe
(pharmaceutical industry and vaccine industry); EuropaBio (biotechnology industry); and MedTech
Europe (medical technology industry).
IHI JU aims to pioneer a new, more integrated approach to health research and builds on the experience
gained from the Innovative Medicine Initiative 2 Joint Undertaking (IMI2 JU).
IHI JU aims to translate health research and innovation into real benefits for patients and society, and
ensure that Europe remains at the cutting edge of interdisciplinary, sustainable, patient-centric health
research. Health research and care increasingly involve diverse sectors. By supporting projects that bring
these sectors together, IHI JU will pave the way for a more integrated approach to health care, covering
prevention, diagnosis, treatment, and disease management.
As current health challenges and threats are global, IHI JU should be open to participation by
international academic, industrial and regulatory actors, in order to benefit from wider access to data and
expertise, to respond to emerging health threats and to achieve the necessary societal impact, in
particular improved health outcomes for Union citizens

View this resource Bookmark this resource

User-centric Technologies and Optimised Hospital Workflows for a Sustainable Healthcare Workforce

Published by IHI

IHI

The Innovative Health Initiative Joint Undertaking (IHI JU) is a partnership between the European Union
and industry associations representing the sectors involved in healthcare, namely COCIR (medical
imaging, radiotherapy, health ICT and electromedical industries); EFPIA, including Vaccines Europe
(pharmaceutical industry and vaccine industry); EuropaBio (biotechnology industry); and MedTech
Europe (medical technology industry).
IHI JU aims to pioneer a new, more integrated approach to health research and builds on the experience
gained from the Innovative Medicine Initiative 2 Joint Undertaking (IMI2 JU).
IHI JU aims to translate health research and innovation into real benefits for patients and society, and
ensure that Europe remains at the cutting edge of interdisciplinary, sustainable, patient-centric health
research. Health research and care increasingly involve diverse sectors. By supporting projects that bring
these sectors together, IHI JU will pave the way for a more integrated approach to health care, covering
prevention, diagnosis, treatment, and disease management.
As current health challenges and threats are global, IHI JU should be open to participation by
international academic, industrial and regulatory actors, in order to benefit from wider access to data and
expertise, to respond to emerging health threats and to achieve the necessary societal impact, in
particular improved health outcomes for Union citizens.

View this resource Bookmark this resource

Rare As One (Cycle 3)

Published by Chan Zuckerberg Initiative

Chan Zuckerberg

The Chan Zuckerberg Initiative invites applications for five-year projects from patient-led rare disease advocacy organizations to join the Rare As One Network. Grantee organizations will accelerate research within individual disease areas and work across specified areas of scientific focus (channelopathies; ciliopathies; or inborn errors of metabolism) to develop shared research priorities and proposals.

View this resource Bookmark this resource